Drug intelligence / Profile preview

acetaminophen + codeine + caffeine

Development stage
Unknown
Lead developer
Johnson & Johnson
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Acetaminophen + codeine + caffeine is a fixed-dose combination oral analgesic containing three active ingredients: - **Acetaminophen** (also known as paracetamol) is an analgesic and antipyretic that works by inhibiting prostaglandin synthesis in the central nervous system to reduce pain and fever. - **Codeine** is an opioid agonist that acts primarily on the mu-opioid receptor in the brain and spinal cord to provide pain relief through inhibition of ascending pain pathways. - **Caffeine** is a central nervous system stimulant that enhances the analgesic effect of acetaminophen and counteracts drowsiness caused by codeine. This combination is used for short-term relief of mild to moderate pain when other non-opioid treatments are inadequate or not tolerated. Caffeine may also help improve alertness and increase the effectiveness of analgesics[8]. The product carries risks associated with opioids (addiction, abuse, misuse), hepatotoxicity from excessive acetaminophen use, and potential side effects from caffeine such as insomnia or palpitations.

Brand names
Tylenol No. 3Tylenol No. 4ACETAMINOPHEN WITH CODEINE – CAPLET
Other names
acetaminophen/codeine/caffeineparacetamol/codeine/caffeine
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)ADORA1 (Adenosine receptor A1 subtype)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)MOR (Mu opioid receptor)

Beyond the preview

Go deeper on acetaminophen + codeine + caffeine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on acetaminophen + codeine + caffeine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call